Spectrum Pharmaceuticals Stock News

NEW YORK, January 26, 2022: S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600: • Constellation Energy Corp. (NASD:CEG) will replace The Gap Inc. (NYSE:GPS) in the S&P 500, The Gap will replace Jack in the Box Inc. (NASD:JACK) in the S&P MidCap 400, and Jack in the Box will replace Spectrum Pharmaceuticals Inc.(NASD:SPPI) in the S&P SmallCap 600 prior to the opening of trading on Thursday, February 3.

PolarityTE (PTE) announces removal of clinical hold on a proposed pivotal study to evaluate its SkinTE for chronic cutaneous ulcers. PolarityTE plans to start enrollment in the next few months.

NEW YORK , Jan. 14, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SXTC, SPCE, C, NVAX, and SPPI. Full story available on Benzinga.com

Spectrum Pharmaceuticals, Inc. (SPPI) shares closed today at 0.9% above its 52 week low of $1.15, giving the company a market cap of $190M. The stock is currently down 8.7% year-to-date, down 69.1% over the past 12 months, and down 75.9% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 58.4% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.6. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 182.8% The company's stock price performance over the past 12 months lags the peer average by -6639.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Spectrum Pharmaceuticals, Inc. (SPPI) shares closed 0.8% lower than its previous 52 week low, giving the company a market cap of $208M. The stock is currently flat year-to-date, down 63.5% over the past 12 months, and down 73.5% over the past five years. This week, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 53.5% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.6. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -100.0% The company's stock price performance over the past 12 months lags the peer average by -2385.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

The stock price of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) fell by 11.19% in the most recent trading session. This is why it happened.

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Liquidia Appoints Pharma Industry Veteran Roger Jeffs As CEO Liquidia Corporation (NASDAQ: LQDA) annou

(PR-inside.com) SAN DIEGO, CA / ACCESSWIRE / December 22, 2021 / Shareholder rights law firm Robbins LLP is investigating Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) to determine whether certain Spectrum officers and directors violated the Securities Exchange Act of 1934 and breached fiduciary duties to shareholders. Spectrum is a biopharmaceutical company that develops and commercializes oncology and hematology drug products. One product the Company has under development is ROLONTIS (eflapegrastim), a novel long-lasting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia. If you would like more information about Spectrum Pharmaceuticals, Inc.''s misconduct, click here. Spectrum Pharmaceuticals, Inc. (SPPI) May Have Materially Misrepresented the Likelihood ROLONTIS Would be ..

Investors need to pay close attention to Spectrum Pharmaceuticals (SPPI) stock based on the movements in the options market lately.

Investors need to pay close attention to Spectrum Pharmaceuticals (SPPI) stock based on the movements in the options market lately.

Looking for potential short squeeze penny stocks? Start by looking at short interest The post Best Penny Stocks To Buy Now? 10 Short Squeeze Stocks To Watch appeared first on Penny Stocks to Buy, Pick

Looking for potential short squeeze penny stocks? Start by looking at short interest The post Best Penny Stocks To Buy Now?

The heavy selling pressure might have exhausted for Spectrum Pharma (SPPI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street ana

In the last trading session, 3.54 million Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) shares changed hands as the companys beta touched 1.90. With the companys per share price at $1.37 changed hands at -$0.21 or -13.29% during last session, the market valuation stood at $259.09M. SPPIs last price was a discount, traded about -282.48% off its 52-week SPPI Stock: More Upside For Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI)? Read More »